Leukemia

Get Latest Update About Chronic Lymphocytic Leukemia on Webcast

by
OSU Wexner Medical Center logo

Get Latest Update About Chronic Lymphocytic Leukemia on Webcast.  This webcast will discuss Chronic Lymphocytic Leukemia. This presentation will first discuss the approach and diagnosis to lymphocytosis. It will use case presentations to highlight the presentation and evaluation of chronic lymphocytic leukemia (CLL). The presenter will also review complications and health maintenance implications for CLL. The second half of the talk will discuss staging and risk stratification. The presenter will review the rationale for observation and indications for treatment as well as the various different treatment options and their associated side effects.

Patients with CLL can have nonspecific symptoms like fatigue and lymphadenopathy—or be entirely asymptomatic. As a result, many cases of CLL are first detected incidentally through routine bloodwork showing lymphocytosis. Unlike many cancers, CLL often progresses so slowly that some patients may not need treatment. Others may not be so lucky and suffer devastating complications such as cytopenias, infections, and secondary malignancies. On this webcast, we’ve invited two Ohio State University’s Hematology experts who both specialize in CLL to discuss this common subtype of Leukemia. How do we diagnose it? And how do we manage it? We’re pleased to introduce Assistant Professor of Hematology Dr. Aseel Alsouqi. Aseel treats not only patients with CLL but also non-Hodgkin’s lymphoma and is an investigator on several clinical trials for leukemia and lymphoma. We also have Associate Professor of Hematology Dr. Seema Bhat. In addition to her clinical treating of patients with CLL, Seema is also a principal investigator on clinical trials for novel CLL therapies.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Learn the basic diagnostic work up for CLL
  • Understand the health implications of CLL
  • Understanding Staging and Risk Stratification of CLL
  • Understand rationale of observation for early-stage asymptomatic patients with CLL and approach to select treatment for CLL when indicated.

You’ll also learn about the following:

  • Prognosis
  • Evolution of CLL
  • PCP’s role
  • Therapies
  • CLL Patients in the Hospital

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Webcast Producer at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

Watch Online Webcast To Get An Updcate on Leukemia

by

OSU Wexner Medical Center logo Watch Online Webcast To Get An Updcate on Leukemia. Today, a new case of Leukemia is diagnosed nearly every 10 minutes in the United States. But fortunately, leukemia treatment is also advancing at a fast rate. The 5-year survival has more than quadrupled since the 1960s. To discuss with us the presentation, diagnosis, prognosis and treatment is one of Ohio State University James Cancer Hospital’s Hematology experts. We’re pleased to introduce Assistant Professor of Medicine Dr. Karilyn Larkin. Karilyn specializes in treating Leukemia and is a member of the Leukemia Research Program at OSU’s Comprehensive Cancer Center.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • To recognize presentation of leukemia and differentiate emergent from non-emergent
  • To become familiar with the terminology used to describe treatment course and responses

You’ll also learn about the following:

  • Blood Cancers
  • Detection
  • White blood cells
  • Recurrence
  • Survivorship

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Webcast Discusses Chronic Lymphocytic Leukemia

by

OSUWexnerbloglogo2014 On-line Webcast Discusses Chronic Lymphocytic Leukemia. On this CME webcast, we’re going to bring you up to date on the latest about chronic lymphocytic leukemia, or CLL. Joining us is hematologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Kerry Rogers. And also hematologist and Associate Professor of Internal Medicine from OSU and the James Cancer Hospital, Dr. Jennifer Woyach.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: CLL is a chronic lymphoid malignancy which does not need treatment at diagnosis if asymptomatic and has a survival of many years; CLL patients are at higher risk for second cancers or infection so it is important so all CLL patients with CLL should get all age appropriate cancer screenings and vaccinations; UNDERSTAND indications for treatment in CLL and the rationale for the watch and wait approach; and UNDERSTAND some serious side effects that can occur with oral targeted therapies in CLL.

You’ll also learn about the following:

  • Risks for CLL
  • Current approach to treatment of CLL
  • Roles and limitations of automated WBC differentials
  • Initial approach to lymphocytosis
  • Emerging trends in first line treatment of CLL
  • Role of age of the patient in therapeutic decision making
  • Stem cell transplants

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.